BC
TEVA icon

Brinker Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Brinker Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17,454
Closed -$307K – 1007
2017
Q3 		$307K Sell
17,454
-4,934
-22% -$111K 0.01% 805
2017
Q2 		$744K Sell
22,388
-352
-2% -$10.9K 0.03% 444
2017
Q1 		$730K Sell
22,740
-11,947
-34% -$408K 0.03% 481
2016
Q4 		$1.26M Buy
34,687
+26,296
+313% +$1.05M 0.07% 252
2016
Q3 		$386K Buy
8,391
+1,882
+29% +$98.2K 0.04% 233
2016
Q2 		$327K Buy
6,509
+1,652
+34% +$87.9K 0.03% 220
2016
Q1 		$259K Buy
+4,857
New +$285K 0.02% 229

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return